BioSyent Inc. (TSXV:RX)
Canada flag Canada · Delayed Price · Currency is CAD
15.31
+0.11 (0.72%)
At close: Mar 18, 2026

BioSyent Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
8.637.276.465.466.283.8
Depreciation & Amortization
0.860.590.460.450.460.51
Stock-Based Compensation
0.620.550.510.440.330.27
Other Adjustments
-0.76-0.64-0.92-0.31-0.22-0.17
Change in Receivables
-1.450.40.24-0.43-0.960.21
Changes in Inventories
-0.240.57-1.48-2.44-0.130.07
Changes in Accounts Payable
0.16-1.080.011.5-0.160.94
Changes in Income Taxes Payable
0.060.29-0.210.22-0.150.1
Changes in Unearned Revenue
-0.180.68-0.03-0.15-0.620.84
Changes in Other Operating Activities
0.050.040.010.2-0.150.34
Operating Cash Flow
8.148.665.054.954.676.89
Operating Cash Flow Growth
21.11%71.39%2.15%5.86%-32.19%56.63%
Capital Expenditures
-0.06-0.04-0.06-0.05-0.08-0.01
Purchases of Intangible Assets
-0.26-4.63-0.11-0.47-0.01-0.16
Other Investing Activities
2.97.961.06-10.27-4.743.56
Investing Cash Flow
2.593.290.88-10.79-4.843.39
Issuance of Common Stock
0.260.250.070.040.010.01
Repurchase of Common Stock
-5.12-5.76-3.7-3.69-1.85-3.14
Net Common Stock Issued (Repurchased)
-4.86-5.51-3.63-3.65-1.84-3.13
Common Dividends Paid
-2.2-2.08-1.91-0.48--
Other Financing Activities
-0.24-0.24-0.24-0.24-0.24-0.24
Financing Cash Flow
-6.97-7.83-5.78-4.37-2.08-3.37
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.030.01-0.030.04-0.02-0.06
Net Cash Flow
1.714.130.12-10.17-2.266.85
Free Cash Flow
8.088.6254.94.596.88
Free Cash Flow Growth
-6.27%72.58%1.91%6.79%-33.29%76.55%
FCF Margin
19.16%24.61%15.81%17.55%16.04%30.81%
Free Cash Flow Per Share
0.700.730.410.390.360.53
Levered Free Cash Flow
9.298.315.165.25.446.57
Unlevered Free Cash Flow
8.097.554.364.875.36.42
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.